The problem with PAB is it cannot sustain its SP without some form of partnering or sponsorship with Big Pharma and/or positive human Clinical Trial results. Until then I wouldn't be surprised to see it drift into the 1-2 range.
A lot of patience is required as there is a very long way to go yet. Its just a traders game at the moment.
I have held this stock for 7 years now, and progressively averaging down. I'll be keeping an eye on the Cash in Bank situation, as soon as they need more $$$ you can bet there will be a flurry of positive announcements.
PAB chart, page-805
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $1.86K | 310.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1285855 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 4958674 | 5 |
View Market Depth
| Last trade - 12.29pm 26/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |